India Allows Compulsory Licensing of Bayer The decision is likely to open up the field for the generics industry or force innovative companies to make drugs more affordable. But will it also affect innovation? BioSpectrum explores the two sides of the story The globally watched case related to an Indian pharma company's request to the… Continue reading Compulsory Licensing of Bayer’s Patented Cancer Drug Sorafenib Granted to Natco Pharma in India